Therapeutic Protein Delivery Systems

2022 ◽  
pp. 345-380
Author(s):  
Sarfaraz K. Niazi
2015 ◽  
Vol 3 (43) ◽  
pp. 8477-8485 ◽  
Author(s):  
Yuting Niu ◽  
Meihua Yu ◽  
Jun Zhang ◽  
Yannan Yang ◽  
Chun Xu ◽  
...  

Silica nanoparticles with controllable surface roughness have been successfully prepared for therapeutic anti-pAkt antibody delivery.


Nanoscale ◽  
2021 ◽  
Author(s):  
Yafei Li ◽  
Yang Zhou ◽  
Tianyi Wang ◽  
Kaiqi Long ◽  
Yaming Zhang ◽  
...  

Numerous recently developed therapies have highlighted the advantages of using proteins as therapeutics. However, in many protein delivery systems, the complicated carrier designs, low loading content, and off-targeting phenomenon have...


Author(s):  
Ashish Jain ◽  
Aviral Jain ◽  
Arvind Gulbake ◽  
Satish Shilpi ◽  
Pooja Hurkat ◽  
...  

Spine ◽  
2002 ◽  
Vol 27 (Supplement) ◽  
pp. S16-S23 ◽  
Author(s):  
Howard Seeherman ◽  
John Wozney ◽  
Rebecca Li

2015 ◽  
Vol 18 (3) ◽  
pp. 396 ◽  
Author(s):  
Mustafa Kotmakçı ◽  
Vildan Bozok Çetintaş

A new platform for drug, gene and peptide-protein delivery is emerging, under the common name of “extracellular vesicles”. Extracellular vesicles (EVs) are 30-1000 nm-sized cell-derived, liposome-like vesicles. Current research on EVs as nano-delivery systems for small-molecule drugs and genetic material, reveal that these tiny, biologically-derived vesicles carry a great potential to boost the efficacy of many therapeutic protocols. Several features of EVs; from efficacy to safety, from passive to active targeting ability, the opportunity to be biologically or chemically labelled, and most importantly, their eobiotic origin make them promising candidate for development of the next generation personalized nanomedicines. The aim of this article is to provide a view on the current research in which EVs are used as drug/genetic material delivery systems. Their application areas, drug loading and targeting strategies, and biodistribution properties are discussed.This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.


Biomaterials ◽  
2012 ◽  
Vol 33 (6) ◽  
pp. 1929-1938 ◽  
Author(s):  
Nina Seidel ◽  
Johannes Sitterberg ◽  
Wolfgang Vornholt ◽  
Udo Bakowsky ◽  
Michael Keusgen ◽  
...  

2013 ◽  
Vol 13 (5) ◽  
pp. 641-649 ◽  
Author(s):  
Peter C. Griffiths ◽  
Nicolo Mauro ◽  
Damien M. Murphy ◽  
Emma Carter ◽  
Simon C. W. Richardson ◽  
...  

2011 ◽  
Vol 11 (6) ◽  
pp. 560-567 ◽  
Author(s):  
Kamran Majid ◽  
Michael D. Tseng ◽  
Kevin C. Baker ◽  
Alma Reyes-Trocchia ◽  
Harry N. Herkowitz

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Ashish Ranjan Sharma ◽  
Shyamal Kumar Kundu ◽  
Ju-Suk Nam ◽  
Garima Sharma ◽  
C. George Priya Doss ◽  
...  

Proteins and genes of therapeutic interests in conjunction with different delivery systems are growing towards new heights. “Next generation delivery systems” may provide more efficient platform for delivery of proteins and genes. In the present review, snapshots about the benefits of proteins or gene therapy, general procedures for therapeutic protein or gene delivery system, and different next generation delivery system such as liposome, PEGylation, HESylation, and nanoparticle based delivery have been depicted with their detailed explanation.


Sign in / Sign up

Export Citation Format

Share Document